- Home
- IPHA vs ISPR Comparison
IPHA vs ISPR Comparison
Compare IPHA & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- ISPR
- Stock Information
- Founded
- IPHA 1999
- ISPR 2019
- Country
- IPHA France
- ISPR United States
- Employees
- IPHA N/A
- ISPR N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- ISPR Medicinal Chemicals and Botanical Products
- Sector
- IPHA Health Care
- ISPR Health Care
- Exchange
- IPHA Nasdaq
- ISPR Nasdaq
- Market Cap
- IPHA 160.1M
- ISPR 152.0M
- IPO Year
- IPHA 2019
- ISPR 2023
- Fundamental
- Price
- IPHA $2.11
- ISPR $2.91
- Analyst Decision
- IPHA Strong Buy
- ISPR Strong Buy
- Analyst Count
- IPHA 1
- ISPR 2
- Target Price
- IPHA $11.00
- ISPR $10.00
- AVG Volume (30 Days)
- IPHA 13.4K
- ISPR 34.2K
- Earning Date
- IPHA 09-11-2025
- ISPR 09-10-2025
- Dividend Yield
- IPHA N/A
- ISPR N/A
- EPS Growth
- IPHA N/A
- ISPR N/A
- EPS
- IPHA N/A
- ISPR N/A
- Revenue
- IPHA $20,831,349.00
- ISPR $144,700,345.00
- Revenue This Year
- IPHA $278.51
- ISPR N/A
- Revenue Next Year
- IPHA $70.16
- ISPR $35.39
- P/E Ratio
- IPHA N/A
- ISPR N/A
- Revenue Growth
- IPHA N/A
- ISPR N/A
- 52 Week Low
- IPHA $1.29
- ISPR $2.09
- 52 Week High
- IPHA $3.51
- ISPR $7.79
- Technical
- Relative Strength Index (RSI)
- IPHA 60.15
- ISPR 54.08
- Support Level
- IPHA $1.71
- ISPR $2.59
- Resistance Level
- IPHA $2.63
- ISPR $3.04
- Average True Range (ATR)
- IPHA 0.14
- ISPR 0.18
- MACD
- IPHA 0.03
- ISPR -0.03
- Stochastic Oscillator
- IPHA 41.83
- ISPR 65.70
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.